The relaxation of regulations governing the manufacture and sale of new medicines to increase their availability should not be accompanied by a lifting of all regulations that restrict industrial activity generally  Unless strict environmental regulations are maintained, endangered species of plants and animals will become extinct
And since a large majority of new medicines are derived from plants and animals, a general deregulatory approach could actually undermine the original intent of the relaxation of regulations governing the manufacture and sale of new medicines
a link between the extinction of species and the potentially decreased availability of new medicines